Literature DB >> 27401325

Renal cell carcinoma.

Axel S Merseburger1, Börje Ljungberg2, Axel Bex3.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 27401325     DOI： 10.1007/s00345-016-1892-5

Source DB:  PubMed          Journal:  World J Urol        ISSN： 0724-4983            Impact factor:   4.226


× No keyword cloud information.
  6 in total

1.  Potentially curable recurrent disease after surgically managed non-metastatic renal cell carcinoma in low-, intermediate- and high-risk patients.

Authors:  Y A M Kuijpers; R P Meijer; G N Jonges; J de Jong; J L H R Bosch; S Horenblas; A Bex
Journal:  World J Urol       Date:  2016-04-07       Impact factor: 4.226

2.  A prospective risk-stratified follow-up programme for radically treated renal cell carcinoma patients: evaluation after eight years of clinical use.

Authors:  Christian Beisland; Gigja Guðbrandsdottir; Lars A R Reisæter; Leif Bostad; Karin M Hjelle
Journal:  World J Urol       Date:  2016-02-27       Impact factor: 4.226

3.  Resection of metastasis and local recurrences of renal cell carcinoma after presurgical targeted therapy: probability of complete local control and outcome.

Authors:  Bernhard Brehmer; Caroline Kauffmann; Christian Blank; Axel Heidenreich; Axel Bex
Journal:  World J Urol       Date:  2016-06-10       Impact factor: 4.226

4.  Renal cell carcinoma recurrences and metastases in primary non-metastatic patients: a population-based study.

Authors:  Saeed Dabestani; Andreas Thorstenson; Per Lindblad; Ulrika Harmenberg; Börje Ljungberg; Sven Lundstam
Journal:  World J Urol       Date:  2016-02-05       Impact factor: 4.226

5.  Comparison of pre-treatment MSKCC and IMDC prognostic risk models in patients with synchronous metastatic renal cell carcinoma treated in the era of targeted therapy.

Authors:  Allard Noe; Roderick E de Bruijn; Christian Blank; Simon Horenblas; John Haanen; Axel Bex
Journal:  World J Urol       Date:  2016-02-01       Impact factor: 4.226

6.  Adherence to guideline recommendations for management of clinical T1 renal cancers in the Netherlands: a population-based study.

Authors:  Katja K H Aben; Susanne Osanto; Christina A Hulsbergen-van de Kaa; Patricia M Soetekouw; Daphne Stemkens; Axel Bex
Journal:  World J Urol       Date:  2016-05-13       Impact factor: 4.226
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.